Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Israeli Strikes on Iranian Fuel Depots Raise Strategic Concerns — and Renew Focus on Middle East Tensions

Israeli Strikes on Iranian Fuel Depots Raise Strategic…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Business as Usual—While Bible Prophecy Is Unfolding Before Our Eyes

“As It Was…” Why Jesus’ Warning About Noah and Lot Sounds…
Read more